First Trust Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.81M | Buy |
|
|||||
|
2025
Q1 | $2.37M | Buy |
|
|||||
|
2024
Q4 | $977K | Sell |
|
|||||
|
2024
Q3 | $1.62M | Buy |
|
|||||
|
2024
Q2 | $575K | Sell |
|
|||||
|
2024
Q1 | $1.73M | Sell |
|
|||||
|
2023
Q4 | $1.59M | Buy |
|
|||||
|
2023
Q3 | $1.41M | Buy |
|
|||||
|
2023
Q2 | $1.05M | Buy |
|
|||||
|
2023
Q1 | $563K | Buy |
|
|||||
|
2022
Q4 | $527K | Sell |
|
|||||
|
2022
Q3 | $2.05M | Sell |
|
|||||
|
2022
Q2 | $1.92M | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $2.94M | Sell |
|
|||||
|
2021
Q2 | $6.2M | Buy |
|
|||||
|
2021
Q1 | $2.17M | Buy |
|
|||||
|
2020
Q4 | $1.98M | Buy |
|
|||||
|
2020
Q3 | $1.3M | Buy |
|
|||||
|
2020
Q2 | $1.41M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $448K | Buy |
|
|||||
|
2019
Q3 | $413K | Sell |
|
|||||
|
2019
Q2 | $515K | Buy |
|
|||||
|
2019
Q1 | $474K | Sell |
|
|||||
|
2018
Q4 | $1.07M | Sell |
|
|||||
|
2018
Q3 | $4.69M | Buy |
|
|||||
|
2018
Q2 | $4.61M | Buy |
|
|||||
|
2018
Q1 | $1.62M | Sell |
|
|||||
|
2017
Q4 | $1.7M | Sell |
|
|||||
|
2017
Q3 | $2.25M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $1.82M | Sell |
|
|||||
|
2016
Q4 | $1.92M | Buy |
|
|||||
|
2016
Q3 | $245K | Sell |
|
|||||
|
2016
Q2 | $204K | Sell |
|
|||||
|
2016
Q1 | $635K | Sell |
|
|||||
|
2015
Q4 | $2.23M | Sell |
|
|||||
|
2015
Q3 | $2.76M | Buy |
|